Pacira BioSciences, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
698.86 |
741.74 |
826.16 |
911.96 |
973.00 |
1,033.50 |
| Przychód Δ r/r |
0.00% |
6.14% |
11.38% |
10.39% |
6.69% |
6.22% |
| Przychód (min) |
693.72 |
647.03 |
804.16 |
911.91 |
920.53 |
977.76 |
| Przychód (max) |
702.37 |
826.16 |
854.56 |
912.01 |
1,025.36 |
1,089.11 |
| EBITDA (średnia) |
123.71 |
131.30 |
146.24 |
161.43 |
172.24 |
182.95 |
| EBIT (średnia) |
59.19 |
62.82 |
69.97 |
77.24 |
82.41 |
87.53 |
| EBIT % |
8.47% |
8.47% |
8.47% |
8.47% |
8.47% |
8.47% |
| Zysk netto (średni) |
149.77 |
132.57 |
161.87 |
189.51 |
210.18 |
224.75 |
| Zysk netto % |
21.43% |
17.87% |
19.59% |
20.78% |
21.60% |
21.75% |
| EPS (średnia) |
3.15 |
2.87 |
3.38 |
4.10 |
4.54 |
4.86 |
| Liczba analityków (Przychody) |
6 |
6 |
6 |
5 |
1 |
2 |
| Liczba analityków (EPS) |
5 |
6 |
4 |
2 |
1 |
1 |
| symbol |
PCRX |
PCRX |
PCRX |
PCRX |
PCRX |
PCRX |